Article
Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stress
2024-05-18
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Peripherally restricted cannabinoid CB1 receptor antagonists without central side effects hold promise for treating metabolic disorders including diabetes and obesity. In atherosclerosis, the specific effects of peripheral CB1 signaling in vascular endothelial cells (ECs) remain incompletely understood. <h4>Methods and results</h4> Endothelial expression of the CB1 encoding...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee21f2eb-0299-5430-92a0-f12a379f4a96
- DOI
- 10.1101/2024.05.15.594375
